Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Entera Bio Ltd. stock logo
ENTX
Entera Bio
$2.05
+0.5%
$1.96
$1.41
$2.79
$92.72M1.4667,158 shs44,516 shs
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
$1.88
+0.5%
$1.72
$1.40
$7.88
$83.01M1.56369,136 shs328,689 shs
eXoZymes Inc. stock logo
EXOZ
eXoZymes
$9.25
$12.16
$8.50
$23.99
$77.40MN/A11,602 shs1,872 shs
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
$0.58
-3.0%
$0.64
$0.24
$4.37
$19.75M0.59971,973 shs214,781 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Entera Bio Ltd. stock logo
ENTX
Entera Bio
+0.49%+18.50%+3.02%+14.53%+8.47%
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
+0.53%+9.94%+11.24%+5.03%-67.02%
eXoZymes Inc. stock logo
EXOZ
eXoZymes
0.00%-5.71%-25.10%-14.67%+924,999,900.00%
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
-3.04%-5.41%-17.56%+99.10%-84.49%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Entera Bio Ltd. stock logo
ENTX
Entera Bio
2.1715 of 5 stars
3.55.00.00.00.60.80.0
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
1.0193 of 5 stars
1.02.00.00.02.32.51.3
eXoZymes Inc. stock logo
EXOZ
eXoZymes
N/AN/AN/AN/AN/AN/AN/AN/A
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
4.6638 of 5 stars
3.15.00.04.41.14.21.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Entera Bio Ltd. stock logo
ENTX
Entera Bio
3.00
Buy$10.00387.80% Upside
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
2.00
Hold$2.006.38% Upside
eXoZymes Inc. stock logo
EXOZ
eXoZymes
0.00
N/AN/AN/A
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
2.25
Hold$5.00766.55% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Entera Bio Ltd. stock logo
ENTX
Entera Bio
$223K417.83N/AN/A$0.23 per share8.91
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
N/AN/AN/AN/A$2.81 per shareN/A
eXoZymes Inc. stock logo
EXOZ
eXoZymes
N/AN/AN/AN/A$1.25 per shareN/A
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
N/AN/AN/AN/A$1.18 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Entera Bio Ltd. stock logo
ENTX
Entera Bio
-$9.54M-$0.26N/AN/AN/A-4,525.11%-95.10%-82.77%8/8/2025 (Estimated)
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
-$28.54M-$0.63N/AN/AN/AN/A-23.48%-22.86%8/4/2025 (Estimated)
eXoZymes Inc. stock logo
EXOZ
eXoZymes
-$5.86MN/A0.00N/AN/AN/AN/AN/A
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
-$79.98M-$2.51N/AN/AN/AN/A-181.26%-151.23%8/6/2025 (Estimated)

Latest RLMD, EPIX, EXOZ, and ENTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q2 2025
Entera Bio Ltd. stock logo
ENTX
Entera Bio
-$0.11N/AN/AN/AN/AN/A
8/6/2025Q2 2025
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
-$0.25N/AN/AN/AN/AN/A
8/4/2025Q3 2025
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
-$0.2430N/AN/AN/AN/AN/A
5/12/2025Q1 2025
eXoZymes Inc. stock logo
EXOZ
eXoZymes
N/A-$0.22N/A-$0.22N/AN/A
5/12/2025Q1 2025
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
-$0.31-$0.58-$0.27-$0.58N/AN/A
5/9/2025Q1 2025
Entera Bio Ltd. stock logo
ENTX
Entera Bio
-$0.07-$0.06+$0.01-$0.06N/A$0.04 million
5/8/2025Q2 2025
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
-$0.19-$0.14+$0.05-$0.14N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Entera Bio Ltd. stock logo
ENTX
Entera Bio
N/AN/AN/AN/AN/A
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
N/AN/AN/AN/AN/A
eXoZymes Inc. stock logo
EXOZ
eXoZymes
N/AN/AN/AN/AN/A
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Entera Bio Ltd. stock logo
ENTX
Entera Bio
N/A
13.07
13.07
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
N/A
67.15
67.15
eXoZymes Inc. stock logo
EXOZ
eXoZymes
N/A
6.52
6.52
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
N/A
5.29
5.29

Institutional Ownership

CompanyInstitutional Ownership
Entera Bio Ltd. stock logo
ENTX
Entera Bio
14.11%
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
75.12%
eXoZymes Inc. stock logo
EXOZ
eXoZymes
N/A
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
45.24%

Insider Ownership

CompanyInsider Ownership
Entera Bio Ltd. stock logo
ENTX
Entera Bio
10.38%
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
15.50%
eXoZymes Inc. stock logo
EXOZ
eXoZymes
72.41%
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
20.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Entera Bio Ltd. stock logo
ENTX
Entera Bio
2045.45 million40.73 millionOptionable
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
5044.39 million37.51 millionOptionable
eXoZymes Inc. stock logo
EXOZ
eXoZymes
298.37 million2.31 millionN/A
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
1033.19 million26.32 millionOptionable

Recent News About These Companies

RLMD Relmada Therapeutics, Inc. - Seeking Alpha
Relmada Therapeutics, Inc. (RLMD) - Yahoo Finance
Relmada Therapeutics to hold a virtual meeting

New MarketBeat Followers Over Time

Media Sentiment Over Time

Entera Bio stock logo

Entera Bio NASDAQ:ENTX

$2.05 +0.01 (+0.49%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.09 +0.04 (+2.15%)
As of 07/18/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures. Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and OXM for the treatment of obesity and metabolic diseases. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.

ESSA Pharma stock logo

ESSA Pharma NASDAQ:EPIX

$1.88 +0.01 (+0.53%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.87 -0.01 (-0.53%)
As of 07/18/2025 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

eXoZymes stock logo

eXoZymes NASDAQ:EXOZ

$9.25 0.00 (0.00%)
As of 07/18/2025 10:13 AM Eastern

eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

Relmada Therapeutics stock logo

Relmada Therapeutics NASDAQ:RLMD

$0.58 -0.02 (-3.04%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$0.57 0.00 (-0.69%)
As of 07/18/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.